Benzonatate
Product Images NDC 67296-1450
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 67296-1450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container-label-100mg-100 (4a8b8e96 801e 49de Badb 7be3fbf57baa 02)
Each soft gelatin capsule contains benzonatate, USP. The medication is manufactured by Strides Pharma Science Ltd. and distributed by Strides Pharma Inc. Patients are advised to swallow the capsules whole and not break, chew, dissolve, cut, or crush them. Storage instructions indicate that the capsules should be stored at room temperature, protected from light. Further dosage and use information can be found in the accompanying prescribing information. The product is identified by NDC 64380-712-06 and LOT.*
Container-label-200mg-100 (4a8b8e96 801e 49de Badb 7be3fbf57baa 03)
This is a medication called Benzonatate. It is available in the form of soft gelatin capsules and each capsule contains 200 mg of Benzonatate, USP. The dosage and usage instructions are provided in the accompanying prescribing information. Patients are advised to swallow the capsules whole and not break, chew, dissolve or crush them. They should be stored at room temperature and protected from light. This medication is manufactured by Strides Pharma Science Ltd., India and distributed by Strides Pharma Inc., in East Brunswick, NJ. The product code is mentioned as KRUDRUGSIKTK/25/415/98 and the NDC number is identified as 64380-713-06.*
Container-label-100mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 04)
Each soft gelatin capsule is composed of 100 mg of Benzonatate, USP. Benzonatate capsules should be swallowed whole and not crushed, broken, dissolved, or chewed. It is recommended to store them at 20° to 25°C (68° to 77°F) protected from light, with excursions permitted to 15-30°C (59-86°F) in a tight (USP), child-resistant container. The capsules are distributed by Strides Pharma Inc. with an NDC of 64380-712-07 and are manufactured by Strides Pharma Science Limited located in Bengaluru, India. For more information, consult the accompanying prescribing information.*
Container-label-200mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 05)
This text provides information on the dosage and use of Benzonatate capsules USP, manufactured by Strides Pharma Science Limited in Bengaluru, India, and distributed by Strides Pharma Inc. in East Brunswick, NJ. The capsules should be swallowed whole and not broken, chewed, dissolved, or crushed. They should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15-30°C (50-86°F) and protected from light. Dispensing should be done in a tight, child-resistant container. For more information, refer to the accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.